Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

#RemoteDetailing

- PMLiVE

Should we be concerned about medical progress?

Medical progress, health expenditure, ageing populations and the future of our healthcare systems

Maxor appoints new chief executive officer

Mike Ellis succeeds John Ward

- PMLiVE

FDA approves expanded indication for Gilotrif

US body gives Boehringer Ingelheim’s oral lung cancer treatment the nod

- PMLiVE

AbbVie hepatitis C combo shows high cure rates

Presents promising new phase II data across all six major HCV genotypes

National Institute for Health and Care Excellence NICE logo

NICE backs first Duchenne muscular dystrophy drug

Reverses original decision to reject the therapy in favour of more data

- PMLiVE

Is training a waste of time and money?

How companies can prioritise their  investment to give them the best return

- PMLiVE

Novel drugs and rare diseases drive US prescription drug spend

But increased competition and cost-cutting measures forced price concessions

- PMLiVE

Merck drops once-weekly diabetes drug in US and EU

Says decision is due to “business reasons” not safety or efficacy issues

- PMLiVE

GSK’s morality gene

The firm is mutating in important ways - we should watch carefully

- PMLiVE

Tonic trio return to healthcare communications

Scott Clark, Moira Gitsham and Oliver Parsons reunite at SO What Global

- PMLiVE

UK biotech BioSilta appoints Image Box PR

Adds to recent account wins that include the Cell and Gene Therapy Catapult

Take a walk on the wild side!

The Say Comms team are raising money for The Haemophilia Society with a walk-a-thon sponsor them here http://bit.ly/1MtvDO8

Say Communications

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links